A Double-blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate Safety and Efficacy of AMG 145 in Combination With Statin Therapy in Diabetic Subjects With Hyperlipidemia or Mixed Dyslipidemia
Phase of Trial: Phase III
Latest Information Update: 29 Dec 2017
At a glance
- Drugs Evolocumab (Primary) ; Atorvastatin
- Indications Dyslipidaemias; Hyperlipidaemia
- Focus Registrational; Therapeutic Use
- Sponsors Amgen
- 20 Dec 2017 Status changed from active, no longer recruiting to completed.
- 15 Dec 2017 This trial has been completed in France (end date: 2017-12-06)
- 28 Nov 2017 Planned End Date changed from 4 Dec 2017 to 5 Dec 2017.